NCDs

Punjab Province in Pakistan Signs Agreement With Novartis Access Against Chronic Diseases

Summary: 
  • Poor patients in Punjab will have access to high-quality  medicines against noncommunicable, chronic diseases thanks to agreement between government and Novartis Access
     
  • Punjab government will make medicines available free of charge through public sector hospitals from early 2018 onward
     
  • Pakistan is among the countries most affected by chronic diseases; more than half of its population lives in the Punjab province
Article
  • Poor patients in Punjab will have access to high-quality  medicines against noncommunicable, chronic diseases thanks to agreement between government and Novartis Access
     
  • Punjab government will make medicines available free of charge through public sector hospitals from early 2018 onward
     
  • Pakistan is among the countries most affected by chronic diseases; more than half of its population lives in the Punjab province

Novartis Access and Government of Cameroon Sign Memorandum of Understanding to Fight Chronic Diseases

Summary: 
  • Novartis reaches agreement with Cameroon to supply medicines against chronic diseases for the poorest populations
  • Cameroon Baptist Convention Health Services have started distributing medicines in selected parts of the country; capacity-building activities to kick off this month
  • Cameroon becomes the sixth country to launch Novartis Access
Novartis reaches agreement with Cameroon to supply medicines against chronic diseases for the poorest populations
Press Release
  • Novartis reaches agreement with Cameroon to supply medicines against chronic diseases for the poorest populations
  • Cameroon Baptist Convention Health Services have started distributing medicines in selected parts of the country; capacity-building activities to kick off this month
  • Cameroon becomes the sixth country to launch Novartis Access

Living With Hypertension in Cameroon When You Live on Only a Few Dollars a Day

Alvine strives to get affordable drugs for hypertension in Cameroon
Article

This month like the previous ones, Alvine Nyintché is visiting the Etoug-Ebe Baptist Hospital in Yaounde. Aged 50, Alvine has been diagnosed with high blood pressure seven years ago.

“Most Cameroonians do not have medical insurance. Today, I pay 800 francs CFA every month for my hypertension treatment (about USD 1.5), whereas just a few months back, it cost me 5000 CFA francs. I am a single mother. My two daughters are unemployed and we have to pay rent,” says Alvine, who lives in Briqueterie, one of the largest slums of the Cameroonian capital.

Lessening the Burden of Non-Communicable Diseases

Blog

Fundamental to Pfizer’s approach in supporting global health is helping to ensure that individuals have the opportunity to lead healthy lives.

Call for Solutions by July 31: Submit Initiatives That Address One of Three Global Challenges Through Collaboration

PYXERA Global is Hosting Fall Virtual Event Series on the Youth Skills Gap, Post-Harvest Loss, and Treatable and Preventable NCDs
Press Release

WASHINGTON, July 26, 2017 /3BL Media/ - The time is now to engage partners, begin collaborations, scale solutions, and make progress on solvable problems such as reducing post-harvest loss, bridging youth skills gap and increasing employability, and treating and preventing non-communicable diseases (NCDs). PYXERA Global will host a #GEFlive fall virtual event series on those three solvable problems, starting in September.

Report Calls for Better Measurement of Access-to-Medicine Programs to Support the World’s Poorest

Pharmaceutical companies have long experience in measuring the impact of their business programs. The same should apply to their access-to-medicine efforts
Article

Richard Laing, from the Boston University (BU) School of Public Health and former World Health Organization official, says that many efforts to expand access to medicines fail to gather sufficient evidence on how effective they are. His team at BU recently issued a study highlighting these gaps, and emphasizing the need for companies to better document the impact of their programs.

Better Hearts Better Cities: Launching a Multisector Effort to Combat Hypertension in Low-income Urban Communities

Making our cities into places of wellbeing, exciting growth and opportunity will require every sector to join forces on urban health, says Dr. Ann Aerts, Head of the Novartis Foundation.
Blog

By Dr. Ann Aerts, Head of the Novartis Foundation

Walking through the wealthier streets of cities like Geneva, London or New York, it seems that health and fitness is an international obsession. National food chains boast of fresh ingredients, light options, and low-fat meals. Shelves are stacked with the trendiest superfoods – quinoa, chia seeds, kale and avocado.

Novartis Foundation and Partners Launch Initiative to Tackle Hypertension and Its Root Causes in Low-Income Urban Communities

Better Hearts Better Cities is an initiative to improve cardiovascular health in low-income urban communities by addressing the prevention, management and control of hypertension
Press Release
  • Better Hearts Better Cities is a Novartis Foundation initiative to improve cardiovascular health in low-income urban communities by addressing the prevention, management and control of hypertension.
  • Non-communicable diseases (NCDs), including cardiovascular disease, are a growing health crisis with 75% of NCD deaths occurring in low- and middle-income countries; this is compounded by rapid urbanization.
  • The innovative approach is being tested on three continents: in Mongolia, Senegal, and Brazil.

The Key to Fighting Chronic Disease in South-East Asia: Young People

More than half the ASEAN region’s 630 million people are under age 30. Harald Nusser, Head of Novartis Social Business, says that to fight the rise of chronic disease in South East Asia we need to inform its youth on the importance of healthy lifestyles.
Article

Twitter Chat | Preventing the Preventable, Treating the Treatable: Non-Communicable Diseases

Summary: 

WHEN: Wed, 3/29, 10 – 11 AM, ET

WHERE: Twitter, #GEFlive

Tweet Me: I will join the #GEFlive Twitter chat on #NCDs w/ @PSIimpact @GSK @IntraHealth & @PHIdotorg http://bit.ly/2mCmrvo 3/29, 10 AM ET

Join GSK, PSI, the Public Health Institute, and IntraHealth International Wed, 3/29, 10 - 11 ET, #GEFLive
Press Release

WHEN: Wed, 3/29, 10 – 11 AM, ET

WHERE: Twitter, #GEFlive

Tweet Me: I will join the #GEFlive Twitter chat on #NCDs w/ @PSIimpact @GSK @IntraHealth & @PHIdotorg http://bit.ly/2mCmrvo 3/29, 10 AM ET

Pages

Subscribe to NCDs